Surface Oncology to Participate in the 2023 Guggenheim
CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation......
Brink’s Fourth-Quarter and Full Year 2022 Earnings Release
RICHMOND, Va., Feb. 02, 2023 (GLOBE NEWSWIRE) -- The Brink’s Company (NYSE:BCO), the global leader in total cash management, route-based secure logistics......
Reneo Pharmaceuticals to Participate in SVB Securities
IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the......
Maha Energy announces new management appointments
Maha Energy AB (Publ) (Maha) has reinforced its team by bringing two senior officers to its management. Barbara Bittencourt has been appointed Chief Legal......
ONL Therapeutics to Present at 2023 BIO CEO & Investor
ANN ARBOR, Mich., Feb. 02, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for......
Revolution Medicines to Participate in Upcoming Investor
REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted......
Alamos Gold Reports One of the Best Holes Drilled to Date
TORONTO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today reported new results from ongoing......